[Skip to Navigation]
Views 1,942
Citations 0
November 8, 2021

Six Recurrent Amyloid-Related Imaging Abnormality Episodes in a Patient Treated With Aducanumab

Author Affiliations
  • 1The Neurology Center of Southern California, Temecula
  • 2Department of Neurology and Neurological Sciences, Stanford University, Stanford, California
  • 3Stanford Center for Clinical Research, Stanford University, Stanford, California
  • 4Global Alzheimer's Platform Foundation, San Francisco, California
  • 5Division of Nuclear Medicine & Molecular Imaging, Department of Radiology, Stanford University, Stanford, California
JAMA Neurol. 2022;79(1):87-89. doi:10.1001/jamaneurol.2021.3933
Add or change institution
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words